- Last sale
- Nov 12, 2026 · -1.91%
- Market cap
- $1.99B
- 80.7M shares
- Filings
- 1,034
Q3 2026+16.0% FY25 yoy
Q3 2026+174.9% FY25 yoy
Q3 2026+257.9% FY25 yoy
Q3 2026derived+98.5% FY25 yoy
Q3 2026+164.5% FY25 yoy
Q3 2026+51.7% FY25 yoy
- $1.99B
- 15.7×
- 3.4×
- 1.4×
- 8.15%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $517,145,000 | reported | |
| FY 2024 | 2024-12-31 | $445,764,000 | reported | |
| FY 2023 | 2023-12-31 | $361,051,000 | reported | |
| FY 2022 | 2022-12-31 | $296,536,000 | reported | |
| FY 2021 | 2021-12-31 | $219,514,000 | reported | |
| FY 2020 | 2020-12-31 | $117,483,000 | reported | |
| FY 2019 | 2019-12-31 | $120,368,000 | reported | |
| FY 2018 | 2018-12-31 | $92,008,000 | reported | |
| FY 2017 | 2017-12-31 | $71,953,000 | reported | |
| FY 2016 | 2016-12-31 | $65,085,000 | reported | |
| FY 2015 | 2015-12-31 | $49,503,000 | reported | |
| FY 2014 | 2014-12-31 | $38,190,000 | reported |
Segments
LineFY2025ShareChange
United States$496.60M96%+17.3%
International$20.55M4.0%−7.6%
Total$517.15M
Medical laboratories
Veracyte, Inc. is the 8th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071
CompanyRevenueGrowthNet marginMarket cap
RDNTRadNet, Inc.$2.0B11.5%0.9%$6.0BGHGuardant Health, Inc.$982.0M32.9%42.4%$20.9BCAICaris Life Sciences, Inc.$812.0M97.0%8.4%$6.9B
VCYTVeracyte, Inc. (this company)$517.1M16.0%12.8%$2.0B
CDNACareDx, Inc.$379.8M13.8%5.6%$4.4BCSTLCastle Biosciences Inc$344.2M3.7%7.0%$1.1BFLGTFulgent Genetics, Inc.$322.7M13.8%18.8%$693.9MBLLNBillionToOne, Inc.$305.1M100.0%2.4%$5.3BGRALGrail, Inc.$147.2M17.2%277.5%$5.5BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Veracyte, Inc. · CIK 1384101 · Engraved from SEC EDGAR